NCT01275833终止不适用
Restoration of Atrioventricular Synchrony Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 2
- 主要终点
- Range Finding of Functional and Hemodynamic Changes Using Echocardiographic Determined Measures.
研究概览
简要总结
The objective of the trial is to observe the effects of restoring atrioventricular (AV) synchrony in subjects with prolonged PR intervals. This will be assessed both acutely and chronically using echocardiographic and functional measurements.
详细描述
Same as above.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet current indications for an implantable cardioverter-defibrillator (ICD) implant with:
- •QRS width < 120 msec
- •Left ventricular ejection fraction (LVEF) < 35% (no more than 180 days prior to enrollment)
- •NYHA functional class II/III
- •Optimal pharmacological heart failure therapy
- •PR interval >/= 230 msec
- •Ability to tolerate protocol required programming
- •Access to a telephone line compatible with the LATITUDE® Communicator
- •Subjects in sinus rhythm at the time of the baseline visit and who are expected to remain in sinus rhythm for the duration of the study
- •Age 18 or above, or of legal age to give informed consent specific to state and national law
- •Willing and capable of providing informed consent, undergoing a device implant, participating in all testing associated with this clinical investigation at an approved clinical investigational center and return to the investigational center at the intervals defined by this protocol
排除标准
- •Previously placed pacemaker, ICD, or CRT device
- •Inability or refusal to sign the Informed Consent Form
- •Documented life expectancy of less than 12 months or expected to undergo heart transplant within the next 12 months
- •Have tricuspid valve disease or who are likely to receive a mechanical tricuspid valve during the course of the clinical investigation
- •Inability or refusal to comply with the follow-up schedule
- •Have a neuromuscular, orthopedic, or other noncardiac condition that prevents subject from normal unsupported walking for the six minute hall walk test
- •Have surgically uncorrected primary valvular heart disease
- •Second or third degree atrioventricular block (AVB)
- •Permanent or persistent atrial tachyarrhythmia that is refractory to all therapies
- •Have had cardiac surgery, percutaneous coronary intervention, or myocardial infarction within 3 months of signing consent or who are likely to undergo a cardiac surgery or procedure in the foreseeable future
- •Enrolled in any concurrent study unless written approval has been obtained from Boston Scientific or The Integra Group
- •Women who are pregnant or plan to become pregnant
结局指标
主要结局
Range Finding of Functional and Hemodynamic Changes Using Echocardiographic Determined Measures.
时间窗: 6 months
Echocardiographic measures will include, but not be limited to, left ventricular volumes, left ventricular diameters, and ejection fraction.
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Impact of Atrio-ventricular Optimization With His Bundle Pacing on Treatment of Atrio-ventricular DromotropathyAtrioventricular DyssynchronyAtrioventricular BlockNCT04544345University Medical Centre Ljubljana17
终止
4 期
Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart FailureHeart FailureNCT01512381Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health11
Unknown
不适用
Right Ventricular Resynchronization TherapyRight Ventricular FailureChronic Thromboembolic Pulmonary HypertensionPulmonary HypertensionNCT01163422Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)20
撤回
早期 1 期
An-Art Study: Atrioventricular (AV) Node Ablation in Cardiac Resynchronisation TherapyCongestive Heart FailureNCT00260546University Hospital, Basel, Switzerland
已完成
不适用
Evaluation of VDD Leadless Pacing System During ExerciseBradycardiaPacemaker DDDNCT06094114Universitaire Ziekenhuizen KU Leuven42